Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. (Record no. 30534942)

MARC details
000 -LEADER
fixed length control field 01663 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518081649.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202107s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1600-0641
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.jhep.2019.09.025
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cheng, Ann-Lii
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210707
245 00 - TITLE STATEMENT
Title Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of hepatology
Date of publication, distribution, etc. 02 2020
300 ## - PHYSICAL DESCRIPTION
Extent 307-319 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiogenesis Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents, Immunological
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element B7-H1 Antigen
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers, Tumor
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element CTLA-4 Antigen
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Hepatocellular
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immune Checkpoint Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Liver Neoplasms
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Programmed Cell Death 1 Receptor
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Progression-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element T-Lymphocytes
General subdivision immunology
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hsu, Chiun
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chan, Stephen L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Choo, Su-Pin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kudo, Masatoshi
773 0# - HOST ITEM ENTRY
Title Journal of hepatology
Related parts vol. 72
-- no. 2
-- p. 307-319
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.jhep.2019.09.025">https://doi.org/10.1016/j.jhep.2019.09.025</a>
Public note Available from publisher's website

No items available.